Global healthcare company Abbott announced it had received authorisation from the health ministry’s Department of Medical Equipment and Construction to sell its Panbio COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in Viet Nam
The Ministry of Health (MoH) has recommended not conducting periodic SARS-CoV-2 testing for fully vaccinated workers who received the last shot at least 14 days but not more than 12 months ago, or former patients who have recovered from the disease...
Over 2,250 adults will participate in a phase II/III trial for the new COVID-19 variant vaccine AstraZeneca’s AZD2816 to assess safety and immunogenicity against the SARS-CoV-2 virus, the company reported.
Panasonic Vietnam today announced that the inhibitory effect on the novel coronavirus (SARS-CoV-2) of the air conditioner with nanoe™ X was certified by Texcell, a global contract research organisation.
Johnson & Johnson on July 30 announced that its lead vaccine candidate protected against infection by SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies.
As soon as the first cases of SARS-CoV-2 were confirmed in Da Nang and Quang Ngai, many firms have re-implemented pandemic prevention measures starting early this week.
A test kit detecting SARS-CoV-2 virus researched and developed by a group of scientists from the Viet Nam Military Medical University received Bao Son Award 2020 which’s worth $60,000 in cash.
SK Vietnam on Wednesday donated 100 SARS-CoV-2 test kit sets, which can be used for 10,000 tests, to the Department of Health under Hà Nội People’s Committee in order to support the city''s efforts in controlling the COVID-19 pandemic.
CapitaLand Vietnam (CapitaLand), together with its philanthropic arm, CapitaLand Hope Foundation (CHF), is donating SARS-CoV-2 test kits capable of performing 40,000 tests valued at US$1 million to the Vietnam Fatherland Front Central Committee (VFFCC) and Viet Nam Ministry of Health to support...
Medicago, a Canadian biopharmaceutical company, said it has successfully produced a virus-like particle of the coronavirus after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene.